- Live Stories
- Young Minds
Bharat Biotech confident of receiving WHO nod for emergency use of Covaxin within 2-4 months
Unvaccinated travellers can travel with negative RT-PCR tests prior to travel
Bharat Biotech, on Tuesday, said it is confident that the World Health Organisation (WHO) would approve its Covid-19 jab, Covaxin. This comes days after the Hyderabad-based firm applied to the World Health Organization for the Emergency Use Listing of its Covid-19 vaccine candidate, Covaxin.
Covaxin has now become the second India-made vaccine to apply at the global health agency for authorisation. The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.
“Regulatory approvals for Covaxin are in process in over 60 countries. Emergency Use Authorisations have been obtained in 13 countries with more to follow,” the Indian vaccine manufacturer said.
Unvaccinated travellers can travel with negative RT-PCR tests prior to travel, in the absence of any other country-specific travel restrictions, Bharat Biotech said.
Bharat Biotech, at a meeting on Tuesday with the government on the status of its application before the WHO, said the company was on track and had submitted “90 per cent of the documentation required” for WHO’s authorization, according to a NDTV report.
“The remaining is expected to be submitted in June,” the company said.